These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 6520110

  • 1. A method to determine the affinity of heparin to thrombin and antithrombin III on equilibrium gel permeation chromatography.
    Oshima G, Uchiyama H, Nagasawa K.
    J Biochem; 1984 Oct; 96(4):1033-9. PubMed ID: 6520110
    [Abstract] [Full Text] [Related]

  • 2. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K, Uchiyama H.
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [Abstract] [Full Text] [Related]

  • 3. Dependence of antithrombin III and thrombin binding stoichiometries and catalytic activity on the molecular weight of affinity-purified heparin.
    Nesheim M, Blackburn MN, Lawler CM, Mann KG.
    J Biol Chem; 1986 Mar 05; 261(7):3214-21. PubMed ID: 3949769
    [Abstract] [Full Text] [Related]

  • 4. Studies on the mechanism of the rate-enhancing effect of heparin on the thrombin-antithrombin III reaction.
    Holmer E, Söderström G, Andersson LO.
    Eur J Biochem; 1979 Jan 02; 93(1):1-5. PubMed ID: 436823
    [Abstract] [Full Text] [Related]

  • 5. Molecular weight analysis of antithrombin III-heparin and antithrombin III-thrombin-heparin complexes.
    Pletcher CH, Cunningham MT, Nelsestuen GL.
    J Biol Chem; 1986 Mar 25; 261(9):4143-7. PubMed ID: 3949807
    [Abstract] [Full Text] [Related]

  • 6. Heterogeneity of rat skin heparin chains with high affinity for antithrombin.
    Horner AA.
    Biochem J; 1987 Jun 15; 244(3):693-8. PubMed ID: 3446185
    [Abstract] [Full Text] [Related]

  • 7. Calcium inhibits the heparin-catalyzed antithrombin III/thrombin reaction by decreasing the apparent binding affinity of heparin for thrombin.
    Speight MO, Griffith MJ.
    Arch Biochem Biophys; 1983 Sep 15; 225(2):958-63. PubMed ID: 6625618
    [Abstract] [Full Text] [Related]

  • 8. Fate of thrombin and thrombin-antithrombin-III complex adsorbed to a heparinized biomaterial: analysis of the enzyme-inhibitor complexes displaced by plasma.
    Hatton MW, Rollason G, Sefton MV.
    Thromb Haemost; 1983 Dec 30; 50(4):873-7. PubMed ID: 6198746
    [Abstract] [Full Text] [Related]

  • 9. Effects of different ions on the interactions of heparin with bovine antithrombin III and thrombin.
    Oshima G, Nagasawa K.
    Thromb Res; 1986 May 01; 42(3):375-82. PubMed ID: 3715809
    [Abstract] [Full Text] [Related]

  • 10. Enhancement by heparin of thrombin-induced antithrombin III proteolysis: its relation to the molecular weight and anticoagulant activity of heparin.
    Marciniak E, Gora-Maslak G.
    Thromb Res; 1982 Nov 01; 28(3):411-21. PubMed ID: 7179225
    [Abstract] [Full Text] [Related]

  • 11. The interaction of protein-bound heparin and antithrombin III.
    Shanberge JN, Sridhar CN.
    Ann N Y Acad Sci; 1981 Nov 01; 370():708-13. PubMed ID: 6168228
    [Abstract] [Full Text] [Related]

  • 12. The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, alpha-thrombin.
    Austin RC, Sheffield WP, Rachubinski RA, Blajchman MA.
    Biochem J; 1992 Mar 01; 282 ( Pt 2)(Pt 2):345-51. PubMed ID: 1546950
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
    Bianchini P, Osima B, Parma B, Nader HB, Dietrich CP.
    J Pharmacol Exp Ther; 1982 Feb 01; 220(2):406-10. PubMed ID: 7057400
    [Abstract] [Full Text] [Related]

  • 14. Abolition by dextran sulfate of the heparin-accelerated antithrombin III/thrombin reaction.
    Oshima G, Nagai T, Nagasawa K.
    Thromb Res; 1984 Sep 15; 35(6):601-11. PubMed ID: 6209818
    [Abstract] [Full Text] [Related]

  • 15. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").
    Sambrano JE, Jacobson LJ, Reeve EB, Manco-Johnson MJ, Hathaway WE.
    J Clin Invest; 1986 Mar 15; 77(3):887-93. PubMed ID: 3512602
    [Abstract] [Full Text] [Related]

  • 16. Measurement of the affinities of heparins, naturally occurring glycosaminoglycans, and other sulfated polymers for antithrombin III and thrombin.
    Dawes J.
    Anal Biochem; 1988 Oct 15; 174(1):177-86. PubMed ID: 3218731
    [Abstract] [Full Text] [Related]

  • 17. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M, Petersen LC, Thorsen S.
    J Lab Clin Med; 1984 Aug 15; 104(2):245-56. PubMed ID: 6747440
    [Abstract] [Full Text] [Related]

  • 18. Differential role of fractionated heparin in antithrombin-III proteolysis.
    Marciniak E.
    Blood; 1982 Mar 15; 59(3):576-81. PubMed ID: 7037067
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the kinetic behavior of human and bovine proteins in the heparin-catalyzed antithrombin III/thrombin reaction.
    Cunningham MT, Nelsestuen GL.
    Biochim Biophys Acta; 1987 Jan 05; 911(1):66-70. PubMed ID: 3790599
    [Abstract] [Full Text] [Related]

  • 20. Thrombin-inhibitory activity of whale heparin oligosaccharides.
    Ototani N, Kodama C, Kikuchi M, Yosizawa Z.
    J Biochem; 1984 Dec 05; 96(6):1695-703. PubMed ID: 6530392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.